oxaliplatin
- Product NDC
- 69097-353
- 11-digit product format
- 690970353
- Labeler code
- 69097
- Product ID
- 69097-353_1f8ee714-a349-45a1-9b9a-337c16441498
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaliplatin
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA208523
- Marketing category
- ANDA
- Marketing start
- 2017-02-10
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 100 mg/20mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-353-78 | 69097035378 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-353-78) > 20 mL in 1 VIAL, SINGLE-DOSE | 2017-02-10 | 0000-00-00 | No | No | Current |